Targeted therapy for hematological malignancies

Study of prognostic significance of marrow angiogenesis assessment in patients with De novo acute leukaemia

Tumor suppressor genes in hematological disorders

Evidence of increased angiogenesis in patients with acute myeloid leukemia (AML)

Advances in tumor angiogenesis : From pathogenesis to molecular targeted therapy approaches

Study of bone marrow microvessel density in myeloid leukemias

Angiogenesis in dermatology

Nanotechnology applications in hematological malignancies

Expression of vascular endothelial growth factor and its receptors in acute leukemia

Chemokines and chemokine receptors in haematological disorders